They’ve recently announced a 90% success rate in treating patients with multiple myeloma cancer.
This is an incredible achievement, given that multiple myeloma is considered an incurable cancer.
It involves using Chimeric Antigen Receptor T-Cell Therapy (CAR-T).
Photo: suravid/Depositphotos
Due to the complexity of the treatment, only one patient a week is allowed access to the therapy.
While CAR-T therapy has been around for decades, until now, it has been quite cost-prohibitive.
The researchers are hopeful that the treatment will soon become available in other parts of the world.
